Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Critical Outcome Technologies Inc. Provides Update on HIV-1 Integrase Co-Development Program

publication date: Apr 13, 2010
 | 
author/source: b3c newswire

Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced today the completion of synthesis for the first two novel HIV integrase inhibitors under co-development with a major pharmaceutical partner.

As previously announced, COTI entered into this partnership to advance its HIV-1 integrase inhibitor program.  Under this agreement, COTI retains all data and intellectual property ownership of the drug candidates including the results of the upcoming in vitro experiments to be conducted by the co-development partner.

The next step in the program is for the co-development partner to manage, conduct and fund the agreed upon in vitro experiments in their evaluation of the compounds.  Once these experiments have been completed and the results have been received by COTI, the co-development partner will have an exclusive time period to negotiate a licensing agreement with COTI for the compounds.

"I am pleased to announce this update in our HIV Integrase program," said Dr. Wayne Danter, President and CSO of COTI. "HIV/AIDS represents a major unmet medical need and the progress in our program for novel HIV integrase inhibitors brings COTI one step closer to assisting in the fight against this devastating disease." 

"We are delighted to move these compounds into the next stage of development with our co-development partner," said Michael Cloutier, CEO of COTI. "This is a strategic, cost effective initiative that allows us to rapidly advance our HIV-1 integrase inhibitor program."

For further information please visit www.criticaloutcome.com  



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events